Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Executive Editor - Health, Beauty and Wellness Insight
USA
17+ years of experience
HBW Insight
By Ryan Nelson 08 Oct 2021
At NAD 2021, Adam Waheed, an award-winning content creator with more than 17m social media followers, addressed challenges and legal risks that have escalated in recent years as influencer marketing opportunity exploded in the US and abroad.
HBW Insight
By Ryan Nelson 17 Aug 2021
The agency’s recent request for contractor quotes cites infants and children, people of color, and immunosuppressed individuals among users whose “unique biological characteristics” could require special consideration in the evaluation of cosmetic ingredients. The FDA also is interested in accounting for unique physicochemical aspects of ingredients such as engineered nanomaterials.
HBW Insight
By Ryan Nelson 16 Mar 2021
The specialty retailer, entering Target stores in the fall, is aiming for net sales of $7.2bn to $7.3bn in fiscal 2021, compared with $6.15bn in 2020 and $7.4bn in 2019. President Dave Kimbell will be taking the helm in June while CEO Mary Dillon stays on for one year as executive chair of the board.
HBW Insight
By Ryan Nelson 27 Nov 2020
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
Topic Business Strategies Cosmetics
HBW Insight
By Ryan Nelson 08 Jun 2020
Charlotte’s Web is strengthening its DTC lead while growing its brick-and-mortar retail business, accelerating its pet product distribution and working to close its Abacus Health acquisition announced in March. The Boulder, CO-based CBD product manufacturer posted a 1% decline in net sales for the first quarter, but expects a rapid escalation in the second half of the year.
Topic Coronavirus
HBW Insight
By Ryan Nelson 28 Nov 2019
Industry advocates working to support GRASE determinations for eight UV filters are faced with a dilemma. They would like to share nonpublic studies with the FDA on a confidential basis – at least to get initial temperature readings from the agency as to the studies’ usefulness in addressing data gaps – but under the current OTC monograph framework, no such pathway exists.
HBW Insight
By Ryan Nelson 13 Jun 2019
The Cosmetic Ingredient Review’s newly figured margins of safety for single- and multi-paraben use in cosmetic products are dramatically lower than previous MOSs that informed the Expert Panel’s 2008 “safe as used” conclusions. Whether the panel still deems the MOSs sufficiently protective is the question going into the group’s Sept. 24-25 meeting.
Rose Sheet
By Ryan Nelson 11 Jun 2019
While FDA does not identify specific product types on the agenda for its public workshop on approaches in skin toxicity testing for topical drug products, advocacy and trade groups anticipate sunscreen ingredient testing could be among the discussion topics. Product expansions have been stifled by regulatory concerns, drawing particular attention from the public health community.
Topic FDA
Rose Sheet
By Ryan Nelson 22 Aug 2018
EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.
Topic Policy and regulation
Rose Sheet
By Ryan Nelson 22 Aug 2018
Companies have had two years to prepare for new warning requirements under California’s Prop 65, which go live at the end of August. Attorneys say new warning responsibilities in e-commerce settings are among changes most likely to imperil businesses (and enable bounty hunters).
Topic Business strategies
Rose Sheet
By Ryan Nelson 22 Aug 2018
The agency’s survey of eye-area cosmetics marketed as free of traditional preservatives doesn’t raise any obvious red flags. However, it does point to a possible contamination source and suggests “the limits of preservative activity in cosmetics.”
Topic FDA
Rose Sheet
By Ryan Nelson 17 Aug 2018
Avisco, a biotech startup focused on the antimicrobial properties of the Inula viscosa plant, and IMD Natural Solutions, whose INS Glycolipid mushroom extract purportedly is “up to 80 times more effective than traditional preservatives,” are among winners named Aug. 6 by GC3.
Topic BioPharmaceutical
HBW Insight
20 Oct 2021
HBW Insight
19 Oct 2021
HBW Insight
18 Oct 2021
HBW Insight
17 Oct 2021
HBW Insight
15 Oct 2021
HBW Insight
06 Oct 2021
HBW Insight
01 Oct 2021
HBW Insight
29 Sep 2021
HBW Insight
27 Sep 2021
HBW Insight
24 Sep 2021
HBW Insight
22 Sep 2021
HBW Insight
20 Sep 2021
HBW Insight
19 Sep 2021
HBW Insight
16 Sep 2021
HBW Insight
09 Sep 2021
